Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors.

Sobarzo A, Stonier SW, Radinsky O, Gelkop S, Kuehne AI, Edri A, Herbert AS, Fedida-Metula S, Lutwama JJ, Yavelsky V, Davis C, Porgador A, Dye JM, Lobel L.

EBioMedicine. 2019 Aug;46:215-226. doi: 10.1016/j.ebiom.2019.07.021. Epub 2019 Jul 17.

2.

Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion.

Pleet ML, DeMarino C, Stonier SW, Dye JM, Jacobson S, Aman MJ, Kashanchi F.

Viruses. 2019 May 2;11(5). pii: E410. doi: 10.3390/v11050410. Review.

3.

Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles.

Pleet ML, Erickson J, DeMarino C, Barclay RA, Cowen M, Lepene B, Liang J, Kuhn JH, Prugar L, Stonier SW, Dye JM, Zhou W, Liotta LA, Aman MJ, Kashanchi F.

J Infect Dis. 2018 Nov 22;218(suppl_5):S365-S387. doi: 10.1093/infdis/jiy472.

PMID:
30169850
4.

Marburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses.

Stonier SW, Herbert AS, Kuehne AI, Sobarzo A, Habibulin P, Dahan CVA, James RM, Egesa M, Cose S, Lutwama JJ, Lobel L, Dye JM.

J Exp Med. 2017 Sep 4;214(9):2563-2572. doi: 10.1084/jem.20170161. Epub 2017 Jul 19.

5.

Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease.

Kash JC, Walters KA, Kindrachuk J, Baxter D, Scherler K, Janosko KB, Adams RD, Herbert AS, James RM, Stonier SW, Memoli MJ, Dye JM, Davey RT Jr, Chertow DS, Taubenberger JK.

Sci Transl Med. 2017 Apr 12;9(385). pii: eaai9321. doi: 10.1126/scitranslmed.aai9321.

6.

Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses.

Natesan M, Jensen SM, Keasey SL, Kamata T, Kuehne AI, Stonier SW, Lutwama JJ, Lobel L, Dye JM, Ulrich RG.

Clin Vaccine Immunol. 2016 Aug 5;23(8):717-24. doi: 10.1128/CVI.00107-16. Print 2016 Aug.

7.

Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus Survivors.

Sobarzo A, Stonier SW, Herbert AS, Ochayon DE, Kuehne AI, Eskira Y, Fedida-Metula S, Tali N, Lewis EC, Egesa M, Cose S, Lutwama JJ, Yavelsky V, Dye JM, Lobel L.

Viruses. 2016 May 11;8(5). pii: E133. doi: 10.3390/v8050133.

8.

Inflammatory Signals Regulate IL-15 in Response to Lymphodepletion.

Anthony SM, Rivas SC, Colpitts SL, Howard ME, Stonier SW, Schluns KS.

J Immunol. 2016 Jun 1;196(11):4544-52. doi: 10.4049/jimmunol.1600219. Epub 2016 Apr 22.

9.

Cytokine modulation correlates with severity of monkeypox disease in humans.

Johnston SC, Johnson JC, Stonier SW, Lin KL, Kisalu NK, Hensley LE, Rimoin AW.

J Clin Virol. 2015 Feb;63:42-5. doi: 10.1016/j.jcv.2014.12.001. Epub 2014 Dec 4.

PMID:
25600603
10.

Immune memory to Sudan virus: comparison between two separate disease outbreaks.

Sobarzo A, Eskira Y, Herbert AS, Kuehne AI, Stonier SW, Ochayon DE, Fedida-Metula S, Balinandi S, Kislev Y, Tali N, Lewis EC, Lutwama JJ, Dye JM, Yavelsky V, Lobel L.

Viruses. 2015 Jan 6;7(1):37-51. doi: 10.3390/v7010037.

11.

Transcriptional regulation of IL-15 expression during hematopoiesis.

Colpitts SL, Stonier SW, Stoklasek TA, Root SH, Aguila HL, Schluns KS, Lefran├žois L.

J Immunol. 2013 Sep 15;191(6):3017-24. doi: 10.4049/jimmunol.1301389. Epub 2013 Aug 21.

12.

Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.

Herbert AS, Kuehne AI, Barth JF, Ortiz RA, Nichols DK, Zak SE, Stonier SW, Muhammad MA, Bakken RR, Prugar LI, Olinger GG, Groebner JL, Lee JS, Pratt WD, Custer M, Kamrud KI, Smith JF, Hart MK, Dye JM.

J Virol. 2013 May;87(9):4952-64. doi: 10.1128/JVI.03361-12. Epub 2013 Feb 13.

13.

Thymic and peripheral microenvironments differentially mediate development and maturation of iNKT cells by IL-15 transpresentation.

Castillo EF, Acero LF, Stonier SW, Zhou D, Schluns KS.

Blood. 2010 Oct 7;116(14):2494-503. doi: 10.1182/blood-2010-03-277103. Epub 2010 Jun 25.

14.

Differential mechanisms of memory CD8 T cell maintenance by individual myeloid cell types.

Frasca L, Stonier SW, Overwijk WW, Schluns KS.

J Leukoc Biol. 2010 Jul;88(1):69-78. doi: 10.1189/jlb.1209816. Epub 2010 Mar 30.

15.

Trans-presentation: a novel mechanism regulating IL-15 delivery and responses.

Stonier SW, Schluns KS.

Immunol Lett. 2010 Jan 4;127(2):85-92. doi: 10.1016/j.imlet.2009.09.009. Epub 2009 Oct 7. Review.

16.

Dendritic cells support the in vivo development and maintenance of NK cells via IL-15 trans-presentation.

Castillo EF, Stonier SW, Frasca L, Schluns KS.

J Immunol. 2009 Oct 15;183(8):4948-56. doi: 10.4049/jimmunol.0900719. Epub 2009 Sep 28.

17.

IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity.

Sikora AG, Jaffarzad N, Hailemichael Y, Gelbard A, Stonier SW, Schluns KS, Frasca L, Lou Y, Liu C, Andersson HA, Hwu P, Overwijk WW.

J Immunol. 2009 Jun 15;182(12):7398-407. doi: 10.4049/jimmunol.0802982.

18.

Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation.

Stonier SW, Ma LJ, Castillo EF, Schluns KS.

Blood. 2008 Dec 1;112(12):4546-54. doi: 10.1182/blood-2008-05-156307. Epub 2008 Sep 23.

Supplemental Content

Loading ...
Support Center